Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
EVO-301 by Evommune for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
EVO-301 is under clinical development by Evommune and currently in Phase I for Atopic Dermatitis (Atopic Eczema). According to GlobalData,...
Data Insights
EVO-301 by Evommune for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease): Likelihood of Approval
EVO-301 is under clinical development by Evommune and currently in Phase I for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease). According...